Literature DB >> 17047192

Epigenetic cancer therapy makes headway.

George S Mack.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17047192     DOI: 10.1093/jnci/djj447

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  36 in total

Review 1.  Promoter hypermethylation in prostate cancer.

Authors:  Jong Y Park
Journal:  Cancer Control       Date:  2010-10       Impact factor: 3.302

2.  Tackling the epigenome: challenges and opportunities for collaboration.

Authors:  John S Satterlee; Dirk Schübeler; Huck-Hui Ng
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

3.  Neuroepigenomics: Resources, Obstacles, and Opportunities.

Authors:  John S Satterlee; Andrea Beckel-Mitchener; Roger Little; Dena Procaccini; Joni L Rutter; Amy C Lossie
Journal:  Neuroepigenetics       Date:  2015-01-01

Review 4.  Emerging EZH2 Inhibitors and Their Application in Lymphoma.

Authors:  Jennifer K Lue; Jennifer E Amengual
Journal:  Curr Hematol Malig Rep       Date:  2018-10       Impact factor: 3.952

Review 5.  The MOZ histone acetyltransferase in epigenetic signaling and disease.

Authors:  Samuel Carlson; Karen C Glass
Journal:  J Cell Physiol       Date:  2014-11       Impact factor: 6.384

Review 6.  Epigenetics and Lymphoma: Can We Use Epigenetics to Prime or Reset Chemoresistant Lymphoma Programs?

Authors:  Jennifer K Lue; Jennifer E Amengual; Owen A O'Connor
Journal:  Curr Oncol Rep       Date:  2015-09       Impact factor: 5.075

Review 7.  PAX2 in human kidney malformations and disease.

Authors:  Lyndsay A Harshman; Patrick D Brophy
Journal:  Pediatr Nephrol       Date:  2011-12-03       Impact factor: 3.714

8.  Monozygotic twin pair showing discordant phenotype for X-linked thrombocytopenia and Wiskott-Aldrich syndrome: a role for epigenetics?

Authors:  David Buchbinder; Kari Nadeau; Diane Nugent
Journal:  J Clin Immunol       Date:  2011-06-28       Impact factor: 8.317

9.  Oxidative stress and DNA methylation in prostate cancer.

Authors:  Krishna Vanaja Donkena; Charles Y F Young; Donald J Tindall
Journal:  Obstet Gynecol Int       Date:  2010-06-29

Review 10.  Genomic and Epigenomic Alterations in Cancer.

Authors:  Balabhadrapatruni V S K Chakravarthi; Saroj Nepal; Sooryanarayana Varambally
Journal:  Am J Pathol       Date:  2016-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.